The Relationship Between the Residual Renal Function and Osteoporosis Treatment

Trial Profile

The Relationship Between the Residual Renal Function and Osteoporosis Treatment

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2016

At a glance

  • Drugs Denosumab (Primary) ; Bisphosphonates; Teriparatide
  • Indications Osteoporosis
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Apr 2016 Planned End Date changed from 1 Jan 2016 to 1 Jan 2019.
    • 20 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2018.
    • 09 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top